|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-3-4
|
|
pubmed:abstractText |
This randomized phase II study was conducted to evaluate the efficacy of doxorubicin and docetaxel (DOC) administered either as a combination, an alternating or a sequential regimen in women with metastatic breast cancer. Secondary objectives included overall response, time to progression, survival and safety.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AzliNN,
pubmed-author:BuzziFF,
pubmed-author:CapriGG,
pubmed-author:CrestaSS,
pubmed-author:CunaG Robustelli DellaGR,
pubmed-author:FrevolaLL,
pubmed-author:GianniLL,
pubmed-author:GrasselliGG,
pubmed-author:JirilloAA,
pubmed-author:LelliGG,
pubmed-author:MansuttiMM,
pubmed-author:MartoniAA,
pubmed-author:MurawskyMM,
pubmed-author:SguottiCC,
pubmed-author:TarenziEE,
pubmed-author:TerzoliEE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14998845-Adolescent,
pubmed-meshheading:14998845-Adult,
pubmed-meshheading:14998845-Aged,
pubmed-meshheading:14998845-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14998845-Breast Neoplasms,
pubmed-meshheading:14998845-Disease Progression,
pubmed-meshheading:14998845-Doxorubicin,
pubmed-meshheading:14998845-Female,
pubmed-meshheading:14998845-Humans,
pubmed-meshheading:14998845-Middle Aged,
pubmed-meshheading:14998845-Survival Rate,
pubmed-meshheading:14998845-Taxoids,
pubmed-meshheading:14998845-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer.
|
|
pubmed:affiliation |
Department of Oncology, Istituto Nazionale Tumori, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
